Submissions
This submission is made by CLL Advocates NZ, an organisation representing the interests of Chronic Lymphocytic Leukaemia (CLL) patients and their families. In New Zealand, approximately 2,800 people are diagnosed with blood cancer each year. This number encompasses leukaemia, lymphoma and myeloma. Leukaemia accounts for around 700 cases annually — the majority of these being CLL.
Dr Neil Graham presented to the Health Select Committee on 7 August 2019 to support the submission calling for the Select Committee to strongly recommend funding of two life-saving treatments.
Submission to the Health Select Committee on the funding on life saving medicines ibrutinib and venetoclax for Chronic Lymphocytic Leukaemia (CLL).